Phase 2 Study of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Carcinoma of Unknown Primary

Mise à jour : Il y a 4 ans
Référence : NCT02590055

Femme et Homme

Extrait

It's a phase 2, single arm study of gemcitabine an docetaxel combination in patients with carcinoma of unknown primary.


Critère d'inclusion

  • Carcinoma of Unknown Primary

Liens